guaifenesin (Robitussin, Fenesin, Humibid LA, Mucinex)

From Aaushi
Jump to navigation Jump to search

Introduction

Tradenames: Robitussin, Fenesin, Humibid LA.

Indications

Contraindications

pregnancy category = c

safety in lactation = ?

Dosage

  • adults & children > 12 years of age
    • 5-20 mL PO every 4 hours
    • 600-1200 mg PO every 12 hours
    • maximum 2400 mg QD
  • children 6-12 years of age
    • 5-10 mL/dose
    • 600 mg PO every 12 hours
    • maximum 1200 mg QD
  • children 2-6 years of age
  • increase fluid intake to help loosen mucus Tabs (sustained-release): 600 mg Mucinex (OTC)

Syrup: 100 mg/5 mL.

Adverse effects

Mechanism of action

  • expectorant action through increased output of respiratory fluid, enhancing flow of less viscid secretion
  • evidence is subjective & not well established

More general terms

Component of

References

  1. The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
  2. Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998
  3. Kaiser Permanente Northern California Regional Drug Formulary, 1998
  4. 4.0 4.1 Prescriber's Letter 7(12):67 2000
  5. Prescriber's Letter 9(9):53 2002
  6. Prescriber's Letter 11(1):3 2004 Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=200102&pb=PRL (subscription needed) http://www.prescribersletter.com
  7. Prescriber's Letter 14(7): 2007 Unapproved Timed-release Guaifenesin Products Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=230706&pb=PRL (subscription needed) http://www.prescribersletter.com
  8. 8.0 8.1 8.2 8.3 8.4 Deprecated Reference

Database